Edwards Lifesciences Corporation
(NYSE : EW)

( )
EW PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
ISRGIntuitive Surgical, Inc.
-1.20%518.062.4%$385.68m
MDTMedtronic PLC
-0.72%87.720.6%$361.23m
ABMDABIOMED, Inc.
0.15%419.383.3%$305.71m
ALGNAlign Technology, Inc.
-0.32%362.286.3%$297.32m
ABTAbbott Laboratories
-2.01%61.790.8%$283.97m
BDXBecton, Dickinson and Company
-0.80%245.131.1%$259.38m
TMOThermo Fisher Scientific Inc.
-1.20%208.671.0%$248.97m
BSXBoston Scientific Corporation
-0.66%33.131.1%$192.35m
SYKStryker Corporation
-0.53%173.381.3%$182.39m
EWEdwards Lifesciences Corporation
-0.99%146.671.2%$167.19m
BAXBaxter International Inc.
-1.04%74.001.7%$163.49m
COOCooper Companies, Inc.
-1.82%242.632.2%$106.93m
WATWaters Corporation
-2.32%193.503.4%$100.45m
ZBHZimmer Biomet Holdings, Inc.
-1.97%112.631.7%$95.52m
XRAYDENTSPLY International Inc.
-1.39%44.723.0%$94.41m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. It operates through the following geographical segments: United States, Europe, Japan, and Rest of the World. Its products are categorized into three areas: Surgical Heart Valve Therapy, Transcatheter Heart Valves, and Critical Care. The Surgical Heart Valve Therapy portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The portfolio also includes a diverse line of cardiac surgery systems used during minimally invasive surgical procedures, and cannulae, embolic protection devices and other products used during cardiopulmonary bypass. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. Its portfolio includes technologies designed for nonsurgical replacement of heart valves. The Critical Care portfolio products hemodynamic monitoring systems used to measure a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA..